As part of our mission to accelerate the process of drug discovery and reduce pharmaceutical research costs, we are focusing on a few key strategies at the moment.
Solutions:
Re-Purposing Generic Drugs
We are currently working in the area of matching existing generic drugs with disease proteins, and are building out a framework for implementing this in the coming months.
.
Canditate Molecule Identification
We are looking at identifying molecular candidates for therapies in rare diseases using the tools of molecular docking with the power of data science.